Nrf2/P-glycoprotein axis is associated with clinicopathological characteristics in colorectal cancer.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

• Publication date

  2018-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biopha.2018.05.062PMID 29793178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of Her2-Nrf2 axis in induction of oxaliplatin resistance in colon cancer cells.

  2018cited by this paper
• dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer

  2018cited by this paper
• UVA Irradiation Enhances Brusatol-Mediated Inhibition of Melanoma Growth by Downregulation of the Nrf2-Mediated Antioxidant Response

  2018cited by this paper
• Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy

  2018cited by this paper
• Leptin induces SIRT1 expression through activation of NF‐E2‐related factor 2: Implications for obesity‐associated colon carcinogenesis☆

  2018cited by this paper
• Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer.

  2018cited by this paper
• Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance.

  2017cited by this paper
• The role of Nrf2-Keap1 axis in colorectal cancer, progression, and chemoresistance

  2017cited by this paper
• Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status

  2017cited by this paper
• The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients

  2017cited by this paper
• Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer

  2017cited by this paper
• The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review

  2017cited by this paper
• Expression and correlation of NRF2, KEAP1, NQO-1 and HO-1 in advanced squamous cell carcinoma of the larynx and their association with clinicopathologic features

  2016cited by this paper
• Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival

  2016cited by this paper
• Expression of the Nrf2 and Keap1 proteins and their clinical significance in osteosarcoma.

  2016cited by this paper
• Expression and clinical significance of Kelch-like epichlorohydrin-associated protein 1 in breast cancer.

  2016cited by this paper
• Impact of nuclear factor erythroid-derived 2-like 2 and p62/sequestosome expression on prognosis of patients with gliomas.

  2015cited by this paper
• Concomitance of P-gp/LRP Expression with EGFR Mutations in Exons 19 and 21 in Non-Small Cell Lung Cancers

  2015cited by this paper
• Nrf2 is Useful for Predicting the Effect of Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma

  2014cited by this paper
• De-Differentiation Confers Multidrug Resistance Via Noncanonical PERK-Nrf2 Signaling

  2014cited by this paper
• Luteolin-loaded phytosomes sensitize human breast carcinoma MDA-MB 231 cells to doxorubicin by suppressing Nrf2 mediated signalling.

  2014cited by this paper
• Expression of multidrug resistance proteins in invasive ductal carcinoma of the breast

  2014cited by this paper
• Clinical Significance of Keap1 and Nrf2 in Oral Squamous Cell Carcinoma

  2013cited by this paper
• The association between chemosensitivity and Pgp, GST-π and Topo II expression in gastric cancer

  2013cited by this paper
• Interplay between Epigenetics and Genetics in Cancer

  2013cited by this paper
• Mitochondrial Dysfunction in Cancer

  2013cited by this paper
• Clinicopathologic significance of CXCR4 and Nrf2 in colorectal cancer

  2013cited by this paper
• MDR1-P-glycoprotein behaves as an oncofetal protein that promotes cell survival in gastric cancer cells

  2012cited by this paper
• NRF2 and cancer: the good, the bad and the importance of context

  2012cited by this paper
• Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.

  2012cited by this paper
• NRF2 is overexpressed in ovarian epithelial carcinoma and is regulated by gonadotrophin and sex-steroid hormones.

  2012cited by this paper
• High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors.

  2011cited by this paper
• Production of monoclonal antibodies to P-glycoprotein: its application in detection of soluble and surface P-glycoprotein of leukemia patients

  2010cited by this paper
• Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival.

  2010cited by this paper
• Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.

  2009cited by this paper
• Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells

  2009cited by this paper
• Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer.

  2008cited by this paper
• Increased Susceptibility of Nrf2 Knockout Mice to Colitis-Associated Colorectal Cancer

  2008cited by this paper
• The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research

  2006cited by this paper
• The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase

  2004cited by this paper
• Nrf2-Keap1 defines a physiologically important stress response mechanism.

  2004cited by this paper
• Oxidant signals and oxidative stress.

  2003cited by this paper
• Effects of MDR1/P-glycoprotein expression on prognosis in advanced colorectal cancer after surgery.

  2001cited by this paper
• Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies.

  2000cited by this paper
• Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein.

  2000cited by this paper
• The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

  2000cited by this paper

• The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model

  2026cites this paper
• Tricellulin facilitates colorectal cancer metastasis through activation of the TGFβ/SMAD2/3 signalling pathway

  2025cites this paper
• H89 Reverses Multidrug Resistance in Colorectal Cancer by Inhibiting the ATPase Activity of ABCB1

  2025cites this paper
• NR1I3 inhibits colorectal cancer growth by enhancing PCK1-mediated gluconeogenesis.

  2025cites this paper
• Targeting cytokine and chemokine signaling pathways for enhancing chemo-sensitivity in colorectal cancer

  2025cites this paper
• ML210 Antagonizes ABCB1- Not ABCG2-Mediated Multidrug Resistance in Colorectal Cancer

  2025cites this paper
• Three Ru(II) complexes modulate the antioxidant transcription factor Nrf2 to overcome cisplatin resistance.

  2024cites this paper
• The Dual Role of NRF2 in Colorectal Cancer: Targeting NRF2 as a Potential Therapeutic Approach

  2024cites this paper
• Prediction and verification of targets for α-hederin/oxaliplatin dual-loaded rHDL modified liposomes: Reversing effector T-cells dysfunction and improving anti-COAD efficiency in vitro and in vivo.

  2024cites this paper
• The roles of miR-383 as a diagnostic and prognostic biomarker in human cancers

  2024cites this paper
• Chalcones and Gastrointestinal Cancers: Experimental Evidence

  2023cites this paper
• The role of exosomes in cancer biology by shedding light on their lipid contents.

  2023cites this paper
• Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer

  2023cites this paper
• Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer

  2023cites this paper
• Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer.

  2022cites this paper
• Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response

  2022cites this paper
• In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells

  2022cites this paper
• Dynamic modeling of Nrf2 pathway activation in liver cells after toxicant exposure

  2022cites this paper
• An update of Nrf2 activators and inhibitors in cancer prevention/promotion

  2022cites this paper
• Nrf2/p‑Fyn/ABCB1 axis accompanied by p‑Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non‑small cell lung cancer.

  2022cites this paper
• FXR1 facilitates axitinib resistance in clear cell renal cell carcinoma via regulating KEAP1/Nrf2 signaling pathway

  2022cites this paper
• Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer

  2021cites this paper
• Hepatocyte nuclear factor 4 gamma (HNF4G) is correlated with poor prognosis and promotes tumor cell growth by inhibiting caspase-dependent intrinsic apoptosis in colorectal cancer.

  2021cites this paper
• Nitazoxanide and Cancer Drug Resistance: Targeting Wnt/β-catenin Signaling Pathway.

  2021cites this paper
• The Impact of Nrf2 Silencing on Nrf2-PD-L1 Axis to Overcome Oxaliplatin Resistance and Migration in Colon Cancer Cells

  2021cites this paper
• Reactive oxygen species in cancer: Current findings and future directions

  2021cites this paper
• hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression

  2021cites this paper
• Nrf2, YAP, antioxidant potential, and cancer

  2021cites this paper
• Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery

  2021cites this paper
• A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.

  2020cites this paper
• High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro

  2020cites this paper
• Association of tricellulin expression with poor colorectal cancer prognosis and metastasis

  2020cites this paper
• MicroRNAs and colorectal cancer chemoresistance: New solution for old problem.

  2020cites this paper
• PD‐1/PD‐L1‐dependent immune response in colorectal cancer

  2020cites this paper
• The Potential Role of Nrf2-PD-L1 Axis in Promoting of Oxaliplatin Resistance in Colon Cancer Cells

  2020cites this paper
• Elevated expression of AGGF1 predicts poor prognosis and promotes the metastasis of colorectal cancer

  2019cites this paper
• Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder

  2019cites this paper
• Can Nrf2 Modulate the Development of Intestinal Fibrosis and Cancer in Inflammatory Bowel Disease?

  2019cites this paper
• Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer

  2019cites this paper
• CMAR_A_200998 6079..6090

  2019cites this paper
• Combined effects of chemotherapy and Nrf2 activation in colorectal cancer cells in vitro

  2018cites this paper
• Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study

  2018cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper